Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/10/2025

Vital Parameters to Monitor in Asthma Patients

Core Vital Parameters for Routine Monitoring

  • The American Thoracic Society recommends that peak expiratory flow (PEF) is the single most important objective measure for asthma monitoring and should be measured regularly in all asthmatic patients 1, 2
  • Normal PEF values vary by age, sex, and height; patients should know their personal best value, with daily variability >10% in adults or >13% in children being diagnostic of asthma 1, 3
  • PEF <50% of predicted or personal best indicates severe asthma requiring immediate treatment, and PEF <33% of predicted or personal best is a life-threatening feature 1, 2
  • Respiratory rate >25 breaths/min in adults indicates severe asthma 1, 2
  • Heart rate >110 beats/min in adults indicates severe asthma 1, 2

Critical Parameters in Acute Severe Asthma

  • Arterial blood gases must always be measured in patients with acute severe asthma admitted to hospital, with a normal or elevated PaCO2 in a breathless asthmatic patient being a marker of life-threatening attack 1, 2
  • Severe hypoxia: PaO2 <8 kPa (60 mmHg) despite oxygen therapy is life-threatening 1, 2
  • A low pH or high H+ indicates severe respiratory acidosis 1, 2

Spirometry for Severity Classification

  • Spirometry provides more reliable and reproducible data than PEF alone, with FEV1/FVC ratio should be >70-80% in healthy adults and >90% in healthy children 3
  • FEV1 <70-80% of predicted with reversibility >12% (and >200ml in adults) after bronchodilator confirms asthma 3

Monitoring Frequency

  • Home monitoring: PEF should be measured twice daily at consistent times 3
  • During acute exacerbations: Reassess PEF 15-30 minutes after bronchodilator treatment 1, 2
  • All patients require follow-up within one week of an acute exacerbation 4

Management of Blood Pressure in Asthmatic Patients

Introduction to Beta-Blocker Use

  • The American Thoracic Society recommends that beta-blockers can mask tachycardia, one of the key warning signs of severe asthma exacerbation 5

Monitoring and Assessment

  • A normal or elevated PaCO2 in a breathless asthmatic is a marker of life-threatening attack and may indicate impending respiratory failure 6, 7
  • The severity of asthma attacks is often underestimated due to failure to make objective measurements like peak flow 5, 8

Key Considerations

  • Never assume normal oxygen saturation excludes severe asthma exacerbation in a patient on beta-blockers—this combination is particularly dangerous 7

REFERENCES

6

Arterial Carbon Dioxide Tension Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7

Asthma Exacerbation Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025